Sally Coggins
BVSc (Hons I) MANZCVS (Medicine of Cats), PhD.
Sally graduated from The University of Sydney in 2007 and has practiced as a feline-only clinician since 2010.
She attained memberships in feline medicine with the Australian and New Zealand College of Veterinary Scientists (ANZCVS) in 2012, becoming an examiner with the ANZCVS, and tutoring for the Centre for Veterinary Education.
Following 10 years practicing at The Cat Clinic, Melbourne, where she was a partner and director, Sally turned her focus to research.
Between 2020 and 2024, Sally completed a PhD on antiviral therapies for FIP, conducting both prospective and retrospective studies using remdesivir and GS-441524, and characterized the pharmacokinetics of remdesivir in cats.
She is a passionate educator and has lectured around the world, upskilling veterinarians on how to diagnose and effectively treat FIP. She is now a Postdoctoral Research Fellow at The Sydney School of Veterinary Science, The University of Sydney, continuing her research into feline infectious diseases, specifically feline coronavirus, feline calicivirus and feline retroviruses.